Cyclins and cancer II: Cyclin D and CDK inhibitors come of age

Cell

Volumn 79, Issue 4, 1994, Pages 573-582

  Hunter, Tony ^a   Pines, Jonathan ^b  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; PROTEIN KINASE; PROTEIN KINASE INHIBITOR;

APOPTOSIS; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; DNA DAMAGE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTO ONCOGENE; REVIEW;

ANIMAL; APOPTOSIS; CELL CYCLE; CELL DIVISION; CYCLIN D1; CYCLIN-DEPENDENT KINASES; CYCLINS; DNA DAMAGE; GENE EXPRESSION; HOMEOSTASIS; HUMAN; MITOSIS; MODELS, BIOLOGICAL; MUTATION; NEOPLASMS; ONCOGENE PROTEINS; PROTO-ONCOGENES; S PHASE;

EID: 0027938209     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0092-8674(94)90543-6     Document Type: Review

References (151)

1. Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes
2. Closing the cell cycle circle in yeast G2 cyclin proteolysis initiated at mitosis persists until the activation of G1 cyclin in the next cycle
3. Cyclin D1 is a nuclear protein required for cell cycle progression in G1
4. CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1
5. Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein
6. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene
7. Open questions on p16
8. Expression and amplification of cyclin genes in human breast cancer
9. Rates of p16 (MTS1) mutations in primary tumors with 9p loss
10. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma
11. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells
12. Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle
13. cdk2 is a component of the E2F-cyclin A complex
14. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts
15. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors
16. Physical interaction of the retinoblastoma protein with human D cyclins
17. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest
18. The decision to enter mitosis
19. Differential regulation of E2F trans-activation by cyclin/cdk2 complexes
20. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis
21. WAF1 a potential mediator of p53 tumor suppression
22. Interaction of p107 with cyclin A independent of complex formation with viral oncoproteins
23. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins
24. TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest
25. Phosphorylation of E2F-1 modulates its interaction with the retinoblastoma gene product and the adenoviral E4 19 kDa protein
26. Interaction between human cyclin A and adenovirus E1A-associated p107 protein
27. Evidence that the G1-S and G2-M transitions are controlled by different cdc2 proteins in higher eukaryotes
28. Apoptosis in cancer therapy crossing the threshold
29. Transforming growth factor β effects on expression of G1 cyclins and cyclin-dependent protein kinases
30. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts
31. Cyclin is degraded by the ubiquitin pathway
32. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15
33. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit
34. A link between cyclin A expression and adhesion-dependent cell cycle progression
35. INK4/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function
36. Induction of metaphase arrest in cleaving Xenopus embryos by MAP kinase
37. The vin-1 gene identified by provirus insertional mutagenesis is the cyclin D2
38. INK4B is a potential effector of TGF-β-induced cell cycle arrest
39. The p21 Cdk-interacting protein Cip 1 is a potent inhibitor of G1 cyclin-dependent kinases
40. Oncogenes and cell death
41. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells
42. Rules to replicate by
43. Structure and cell-cycle-regulated transcription of the human cyclin A gene
44. Mediation of c-Myc-induced apoptosis by p53
45. Function of a human cyclic gene as an oncogene
46. Tumor suppressor genes
47. Participation of cyclin A in Myc-induced apoptosis
48. Activation of the phosphatase activity of human cdc25A by cdk2-cyclin E dependent phosphorylation at the G1/S transition
49. Anaphase is initiated by proteolysis rather than by the inactivation of maturation-promoting factor
50. The requirements for protein synthesis and degradation and the control of destruction of cyclins A and B in the meiotic and mitotic cell cycles of the clam embryo
51. Cyclins and cancer
52. Germline p16 mutations in familial melanoma
53. Genomic organization chromosomal localization and independent expression of human cyclin D genes
54. Differential modulation of cyclin gene expression by MYC
55. Amplification and expression of the human cyclin D gene in esophageal cancer
56. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control cell cycle progression and gene expression
57. Cdc25A is a novel phosphatase functioning early in the cell cycle
58. Expression of transcription factor E2F1 induces quiescent cells to enter S phase
59. A cell cycle regulator potentially involved in genesis of many tumor types
60. Rates of p16 (MTS1) mutations in primary tumors with 9p loss
61. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
62. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4
63. k/p1) of cyclin-dependent kinase 4 activation
64. Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1
65. Cyclin E a potential prognostic marker for breast cancer
66. Redundant cyclin overexpression and gene amplification in breast cancer cells
67. Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas
68. Differential phosphorylation of c-Abl in cell cycle determined by cdc2 kinase and phosphatase activity
69. Suppression of cyclin-dependent kinase 4 (cdk4) during induced differentiation of erythroleukemia cells
70. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase
71. D11S128 a putative oncogene on chromosome 11q13 is amplified and expressed in squamous cell and mammary carcinomas and lined to BCL-1
72. Amplification of cyclin genes in colorectal carcinomas
73. A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line
74. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner
75. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor
76. Transcriptional repression of the D-type cyclin-dependent kinases inhibitor p16 by the retinoblastoma susceptibility gene product, pRb
77. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphomas in transgenic mice
78. Oncogenic activity cyclin D1 revealed though cooperation with Ha-ras link between cell cycle control and malignant transformation
79. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
80. Differential induction of transcriptionally active p53 following UV or ionizing radiation defects in chromosome instability syndromes?
81. DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement of cyclin D1 function in G1
82. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines
83. Transformation of mammalian cells by constitutively active MAP kinase kinase
84. J3/cdk4) for mammalian D type G1 cyclins
85. D-type cyclin-dependent kinase activity in mammalian cells
86. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle
87. Activation of cyclin A-dependent protein kinases during apoptosis
88. Identification of G1 kinase activity for cdk6 a novel cyclin D partner
89. Induction of WAF1/CIP1 by a p53-independent pathway
90. Regulation of progression through the G1 phase of the cell cycle by the rum1+ gene
91. Frequent somatic mutation of MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma
92. A novel cyclin encoded by a bcl-linked candidate oncogene
93. Cloning and characterization of human cyclin D3 a cDNA closely related in sequence to the PRAD1/cyclin D1 proto-oncogene
94. Cyclin D1 expression is regulated by the retinoblastoma protein
95. The c-mos proto-oncogene protein kinase turns on and maintains the activity of MAP kinase but not MPF in cell-free extracts of Xenopus oocytes and eggs
96. Cell cycle targets of the DNA tumor viruses
97. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
98. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
99. Ordering S phase and M phase in the cell cycle
100. G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently
101. Relationships between cdc2 kinase DNA cross-linking and cell cycle perturbations induced by nitrogen mustard
102. Cyclin-dependent regulation of G1 in mammalian fibroblasts
103. Mutations and altered expression of genes regulating the cell cycle G1 checkpoint in human cancer
104. E2F-dependent regulation of human MYC trans-activation by cyclins D1 and A overrides tumour suppressor protein function
105. Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts
106. Cyclin A is required at two points in the human cell cycle
107. Lack of cyclin D/Cdk complexes in RB-negative cells correlates with high levels of p16INK4/MTS1 tumour suppress gene product
108. Repression of cyclin D1 a novel function of MYC
109. p27Kip1 a cyclin-Cdk inhibitor links transforming growth factor-β and contact inhibition to cell cycle arrest
110. Kip1, a cyclin-dependent kinase inhibitir and a potential mediator of extracellular antimitogenic signals
111. Mos stimulates MAP kinase in Xenopus oocytes and activates a MAP kinase kinase in vitro
112. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts
113. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators
114. Ecceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system
115. Differences in mitonic control among mammalian cells
116. SIC1 controls the G1 to S transition in S. cerevisiae
117. Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15
118. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
119. Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11; 14)(q13; q32) translocation
120. Alternative splicing of human cyclin E
121. Purified maturation promoting factor phosphorylates pp60 c-src at the sites phosphorylated during fibroblast mitosis
122. Mammalian G1 cyclins
123. cdc2 activation required for apoptosis
124. Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation
125. p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein
126. A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor β-arrested epithelial cells
127. CDC2
128. p16 gene in uncultured tumours
129. Destruction of the CDC28/CLB mitotic kinase is not required for the metaphase to anaphase transition in budding yeast
130. Differential expression and regulation of Cyclin D1 protein in normal and tumor human cells association with Cdk4 is required for Cyclin D1 function in G1 progression
131. p27 a novel inhibitor of G1 cyclin-Cdk protein kinase activity is related to p21
132. The cdk2 kinase is required for the G1-to-S transition in mammalian cells
133. Amplification and overexpression of EXP1 and EXP2/Cyclin D1 genes in human esophageal carcinomas
134. Distinct roles for cyclin-dependent kinases in cell cycle control
135. The p21 cyclin-dependent kinase inhibitor directly controls DNA replication via interaction with PCNA
136. Familial melanoma and p16 a hungjury
137. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma
138. Modification of cyclin A expression by hepatitis B virus DNA integration in a hepatocellular carcinoma
139. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
140. A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle
141. p53 guardian of Rb
142. Inducible acceleration of G1 progression through tetracycline-regulated expression of human cyclin E
143. Growth factor regulation of cyclin D1 mRNA expression through protein synthesis-dependent and-independent mechanisms
144. Characterization of a candidate bcl-1 gene
145. Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts
146. p21 is a universal inhibitor of cyclin kinases
147. Molecular cloning and chromosomal mapping of CCND genes encoding human D-type cyclins
148. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation
149. Mos and the cell cycle the molecular basis of the transformed phenotype
150. p21-containing cyclin kinases exist in both active and inactive states
151. Cyclin A is required in S phase in normal epithelial cells